1.
Mazzanti NA, Scauri C, Domini B, Vassallo C, Cusato S, De FinoC, de MarinisF. Advanced-Metastatic Non-Small-Cell Lung Cancer EGFR-mutated in Italy: patient management costs and potential productivity losses. GRHTA [Internet]. 8Oct.2019 [cited 27Jan.2020];6(1). Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/451